论文部分内容阅读
2000年上半年葛兰素威康公司 1999年葛兰素威康公司的销售业绩和利润都没有达到2位数的增长率,今年公司的业绩有所改善,达到了2位数的销售业绩和利润的增长,虽然,新产品的增长仍然不尽人意。史克公司上半年的销售达到41亿英磅,增长9%。葛兰素威康公司上半年的销售达到46亿英镑,增长12%,税前利润达到16亿英镑,增长20%,营业利润达到14.5亿英镑,增长8%,其中有4000万英镑用于与史克公司合并。公司的纯利润增长22%,达到11.4亿英镑。
In the first half of 2000, Glaxo Wellcome’s sales and profits of Glaxo Wellcome did not reach a two-digit growth rate. This year, the company’s performance improved to reach a two-digit sales figure and Although the growth of profits, the growth of new products is still not satisfactory. In the first half of the year, the company’s sales reached 4.1 billion pounds, an increase of 9%. Glaxo Wellcome’s sales in the first half of the year reached 4.6 billion pounds, an increase of 12%, pre-tax profit reached 1.6 billion pounds, an increase of 20%, operating profit reached 1.45 billion pounds, an increase of 8%, of which 40 million pounds was used for The company merged. The company’s net profit increased by 22% to 1.14 billion pounds.